Market Overview

Goldman Says FDA Response to Energy Drink Safety Review 'Encouraging' for Monster

Share:
Related MNST
18 Stocks Moving In Wednesday's Pre-Market Session
10 Stocks To Watch For August 9, 2017

Commenting on the action in Monster Beverage this afternoon, Goldman Sachs analyst Judy Hong called the FDA's response to the energy drink safety issue "generally benign." Hong believes this should be encouraging for Monster. The analyst believes the most likely outcome related to Durbin's energy drink review will be strong labeling, something which is unlikely to have a material impact on Monster.

Latest Ratings for MNST

DateFirmActionFromTo
Aug 2017Credit SuisseMaintainsOutperform
Mar 2017JP MorganInitiates Coverage OnOverweight
Dec 2016JefferiesUpgradesHoldBuy

View More Analyst Ratings for MNST
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings Movers

 

Related Articles (MNST)

View Comments and Join the Discussion!